IVDR · Annex VIII, Section 2.3 · CLASSIFICATION RULES
IVDR rule 3: The class C list
Updated on November 15, 2026
Official text
Devices are classified as class C if they are intended:
- for detecting the presence of, or exposure to, a sexually transmitted agent;
- for detecting the presence in cerebrospinal fluid or blood of an infectious agent without a high or suspected high risk of propagation;
- for detecting the presence of an infectious agent, if there is a significant risk that an erroneous result would cause death or severe disability to the individual, foetus or embryo being tested, or to the individual's offspring;
- for pre-natal screening of women in order to determine their immune status towards transmissible agents;
- for determining infective disease status or immune status, where there is a risk that an erroneous result would lead to a patient management decision resulting in a life-threatening situation for the patient or for the patient's offspring;
- to be used as companion diagnostics;
- to be used for disease staging, where there is a risk that an erroneous result would lead to a patient management decision resulting in a life-threatening situation for the patient or for the patient's offspring;
- to be used in screening, diagnosis, or staging of cancer;
- for human genetic testing;
- for monitoring of levels of medicinal products, substances or biological components, when there is a risk that an erroneous result will lead to a patient management decision resulting in a life-threatening situation for the patient or for the patient's offspring;
- for management of patients suffering from a life-threatening disease or condition;
- for screening for congenital disorders in the embryo or foetus;
- for screening for congenital disorders in new-born babies where failure to detect and treat such disorders could lead to life-threatening situations or severe disabilities.
IVDR, Annex VIII, Section 2.3, consolidated version of January 10, 2025.
Short link: normiq.app/en/ivdr/annexe/viii/3
In plain words
The rule places in class C devices intended for the purposes it lists, including detection of sexually transmitted agents or of infectious agents in cerebrospinal fluid or blood, companion diagnostics, cancer screening, diagnosis or staging, human genetic testing, management of patients suffering from a life-threatening disease and screening for congenital disorders. Several purposes are subject to a condition on the consequences of an erroneous result: the list is read in the text, point by point.
Explanation written by Normiq; only the official text above is authoritative.
Definitions the rule relies on
- IVDR, Article 2, point 7
‘companion diagnostic’ means a device which is essential for the safe and effective use of a corresponding medicinal product to:
- identify, before and/or during treatment, patients who are most likely to benefit from the corresponding medicinal product; or
- identify, before and/or during treatment, patients likely to be at increased risk of serious adverse reactions as a result of treatment with the corresponding medicinal product;
Examples from the MDCG guidance
The guidance lists these examples under rule 3 (MDCG 2020-16 rev.5). It is not legally binding, and the class always depends on the intended purpose of the device (Annex VIII, Section 1.1).
Class C
Devices intended for the detection of: Chlamydia trachomatis.
MDCG 2020-16 rev.5, 4, Rule 3(a), p. 16
A device intended to identify a genotype, single or multiple genetic and/or genomic variants.
MDCG 2020-16 rev.5, 4, Rule 3(f), p. 23
A faecal occult blood screening test (FOBT) or faecal immunochemical test (FIT) specifically intended to be used in colon cancer screening.
MDCG 2020-16 rev.5, 4, Rule 3(h), p. 27
Devices intended for: HbA1c and blood glucose tests for the management of patients with diabetes.
MDCG 2020-16 rev.5, 4, Rule 3(k), p. 33
Blood gas analyser and the software driving and influencing it are classified as either: Class C (Rule 3j) where the blood gas analyser directly measures a parameter from a specimen (in the absence of a reagent or disposable sensor cassette) AND where an erroneous result in a measured parameter WILL LEAD to a patient management decision resulting in a life-threatening situation.
MDCG 2020-16 rev.5, Annex 1, Example 2, p. 48
Classes and Normiq roadmaps
Rule 3 assigns: Class C. For each, the Normiq roadmap on every market where Annex VIII applies.
The same rule in Switzerland
Devices shall be divided into classes A, B, C and D, taking into account the intended purpose of the devices and their inherent risks. This classification must comply with the provisions of Annex VIII to EU-IVDR.
Fedlex’s English translation, which has no legal force: the ordinance is official only in French, German and Italian.
Classify your device
The tool asks the questions of the 7 rules of the IVDR, one at a time, and gives the indicative class with the rule and its text.
Open the classification tool